Austrian Ministry of Health published COVID-19-related documentation

Apr 2020

The Federal Ministry for Social Affairs, Health, Care, and Consumer Protection (BMSGPK) defined the rules for diagnosis and documentation of COVID-19 in hospitals.

Cases of illness with a confirmed COVID-19 should be coded with the diagnosis code "U07.1 - COVID-19." When this code is used as the main diagnosis, the group HDG05.03 "Pneumonia and bronchiolitis" is used for reimbursement.

In the case of an unconfirmed suspected case, diagnosis code “Z03.8 Observation in other suspected cases” should be used. Quarantine cases (for hospital quarantine) are coded with the code “Z29.0 Isolation as prophylactic measure.”

These diagnoses must also be encrypted for outpatient visits.

BMSGPK also defined the rules for administrative documentation related to the stay at ICU, hospitals not financed by the State Health Fund, and institutions without a cadastral number ("temporary hospital") due to COVID19.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

2022 RIHN and Supplementary list for IVD tests published in France

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

New procedure and diagnostic codes added to the private reimbursement schedule in England

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Theme survey on products for monitoring and diagnostics of sepsis launched by Swedish TLV

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Healthcare Implementation Communique updated in Turkey

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Two more health apps obtained reimbursement in Germany

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.